Association between virus variants, vaccination, previous infections, and post-COVID-19 risk

Association between virus variants, vaccination, previous infections, and post-COVID-19 risk

Objectives: The SARS-CoV-2 Omicron variant has spread rapidly and has been the dominant variant since 2022. The course of acute infection, in a vaccinated population, with Omicron is milder compared with earlier variants. However, little is known about how the occurrence of long-term symptoms after...

Full description

Bibliographic Details
Main Authors:	Sophie Diexer, Bianca Klee, Cornelia Gottschick, Chao Xu, Anja Broda, Oliver Purschke, Mascha Binder, Thomas Frese, Matthias Girndt, Jessica I. Hoell, Irene Moor, Michael Gekle, Rafael Mikolajczyk
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	International Journal of Infectious Diseases
Subjects:	SARS-CoV-2 COVID-19 SARS-CoV-2 variants Vaccination
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971223007026

Similar Items

Insights into early recovery from Long COVID—results from the German DigiHero Cohort
by: Sophie Diexer, et al.
Published: (2024-04-01)

Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination
by: Lisa Paschold, et al.
Published: (2022-05-01)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
by: Ravi Kant, et al.
Published: (2021-11-01)

SARS-CoV-2: Searching for the Missing Variants
by: Emilia Caputo, et al.
Published: (2022-10-01)

Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants
by: Emilia Caputo, et al.
Published: (2022-08-01)

Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
by: Louise Benning, et al.
Published: (2022-08-01)

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
by: Naomi S. Coombes, et al.
Published: (2023-02-01)

Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition
by: Thandeka Nkosi, et al.
Published: (2022-07-01)

Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
by: John A. Lednicky, et al.
Published: (2021-07-01)

Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
by: Eliana Specchiarello, et al.
Published: (2023-04-01)

Analytical evaluation of thirty-two severe acute respiratory syndrome 2 lateral flow antigen tests demonstrates sensitivity remains with the SARS-CoV-2 Gamma lineage
by: Konstantina Kontogianni, et al.
Published: (2022-06-01)

Emergence of Two Distinct SARS-CoV-2 Gamma Variants and the Rapid Spread of P.1-like-II SARS-CoV-2 during the Second Wave of COVID-19 in Santa Catarina, Southern Brazil
by: Dayane Azevedo Padilha, et al.
Published: (2022-03-01)

Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
by: Ali Pormohammad, et al.
Published: (2021-12-01)

Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach
by: Jenifer Mallavarpu Ambrose, et al.
Published: (2021-05-01)

Development of SARS-CoV-2 entry antivirals
by: Meiyue Dong, et al.
Published: (2024-02-01)

RT-PCR Detection of SARS-CoV-2 among Individuals from the Upper Silesian Region—Analysis of 108,516 Tests
by: Adam Konka, et al.
Published: (2021-12-01)

Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions
by: Shi‐ting He, et al.
Published: (2022-12-01)

Differential Impact of SARS-CoV-2 Isolates, Namely, the Wuhan Strain, Delta, and Omicron Variants on Erythropoiesis
by: Suguru Saito, et al.
Published: (2022-08-01)

Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study
by: Giovanni Corrao, et al.
Published: (2022-02-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
by: Iris Medits, et al.
Published: (2022-07-01)

Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
by: Afshin Abdi Ghavidel, et al.
Published: (2021-12-01)

Risk of paediatric multisystem inflammatory syndrome (PIMS-TS) during the SARS-CoV-2 alpha and delta variant waves: National observational and modelling study, 2020–21, England
by: Joseph Shingleton, et al.
Published: (2022-12-01)

Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows
by: Ryan Connor, et al.
Published: (2024-03-01)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)

CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern
by: Yuanhao Liang, et al.
Published: (2021-12-01)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
by: Theocharis G. Konstantinidis, et al.
Published: (2021-06-01)

Chemokine Regulation During Epidemic Coronavirus Infection
by: Shamik Majumdar, et al.
Published: (2021-02-01)

Viral Etiological Agent(s) of Respiratory Tract Infections in Symptomatic Individuals during the Second Wave of COVID-19 Pandemic: A Single Drive-Thru Mobile Collection Site Study
by: Aleksandra Kozinska, et al.
Published: (2022-04-01)

A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States
by: Adam A. Capoferri, et al.
Published: (2022-01-01)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
by: Marianne Graninger, et al.
Published: (2022-05-01)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Inverse association with COVID-19 vaccination status of the incidence of pneumonia after SARS-CoV-2 infection: A nationwide retrospective cohort study
by: Jihun Song, et al.
Published: (2024-04-01)

Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
by: Ana Medel-Martinez, et al.
Published: (2023-09-01)

Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
by: Alfredo Parra-Lucares, et al.
Published: (2022-01-01)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
by: Varghese Edwin Hillary, et al.
Published: (2023-03-01)

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors
by: Francesca Curreli, et al.
Published: (2023-04-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)